Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Shares Outstanding (2016 - 2025)

Apyx Medical's Shares Outstanding history spans 16 years, with the latest figure at $41.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 10.56% year-over-year to $41.8 million; the TTM value through Dec 2025 reached $41.8 million, up 10.56%, while the annual FY2025 figure was $41.8 million, 10.56% up from the prior year.
  • Shares Outstanding reached $41.8 million in Q4 2025 per APYX's latest filing, up from $37819.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $41.8 million in Q4 2025 to a low of $37819.0 in Q3 2025.
  • Average Shares Outstanding over 5 years is $33.7 million, with a median of $34.6 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: changed 0.0% in 2024, then grew 10.56% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $34.4 million in 2021, then increased by 0.55% to $34.6 million in 2022, then grew by 0.13% to $34.6 million in 2023, then grew by 9.09% to $37.8 million in 2024, then increased by 10.56% to $41.8 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Shares Outstanding are $41.8 million (Q4 2025), $37.8 million (Q3 2025), and $37.8 million (Q2 2025).